| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | PUMA BIOTECHNOLOGY | 30,000 | 921,000 | 0.02% | ||
| 102 | JPMORGAN CHASE & CO | 10,300 | 888,000 | 0.02% | ||
| 103 | OBALON THERAPEUTICS INC | 100,000 | 885,000 | 0.02% | ||
| 104 | ADEPTUS HEALTH INC | 107,000 | 817,000 | 0.02% | ||
| 105 | VANTIV INC | 11,400 | 680,000 | 0.01% | ||
| 106 | DOLLAR GEN CORP NEW | 8,500 | 630,000 | 0.01% | ||
| 107 | MEDTRONIC PLC | 7,800 | 556,000 | 0.01% | ||
| 108 | KEMPHARM INC | 165,000 | 487,000 | 0.01% | ||
| 109 | VERTEX PHARMACEUTICALS INC | 6,006 | 442,000 | 0.01% | ||
| 110 | IONIS PHARMACEUTICALS INC COM | 6,000 | 287,000 | 0.01% | ||
| 111 | RADIUS HEALTH INCORPORATED COM NEW | 7,354 | 280,000 | 0.01% | ||
| 112 | CREDICORP LTD | 1,691 | 267,000 | 0.01% | ||
| 113 | OPHTHOTECH CORP | 53,000 | 256,000 | 0.00% | ||
| 114 | ACADIA PHARMACEUTICALS INC COM | 8,184 | 236,000 | 0.00% | ||
| 115 | INNOCOLL HLDGS PLC | 295,184 | 204,000 | 0.00% | ||
| 116 | BLUEBIRD BIO INC COM | 3,225 | 199,000 | 0.00% | ||
| 117 | TRANSENTERIX INC | 150,000 | 195,000 | 0.00% | ||
| 118 | LEXICON PHARMACEUTICALS INC | 11,397 | 158,000 | 0.00% | ||
| 119 | INTERCEPT PHARMACEUTICALS INCORPORATED | 1,439 | 156,000 | 0.00% | ||
| 120 | KERYX BIOPHARMACEUTICALS INCORPORATED | 26,000 | 152,000 | 0.00% | ||
| 121 | ACCELERON PHARMA INC | 5,320 | 136,000 | 0.00% | ||
| 122 | REGENERON PHARMACEUTICALS | 350 | 128,000 | 0.00% | ||
| 123 | KARYOPHARM THERAPEUTICS INC COM | 13,000 | 122,000 | 0.00% | ||
| 124 | SAREPTA THERAPEUTICS INC | 3,304 | 91,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001625244-17-000002, filed 2017.02.06).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
